Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TherapeuticsMD Q2 EPS $0.05 Up From $(0.09) YoY, Sales $1.000M Up From $234.000K YoY

Author: Benzinga Newsdesk | August 12, 2025 03:29pm
TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.05 per share. This is a 155.56 percent increase over losses of $(0.09) per share from the same period last year. The company reported $1.000 million in sales this quarter. This is a 327.35 percent increase over sales of $234.000 thousand the same period last year.

Posted In: TXMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist